Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish
Farmovs
In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19. 

The trial is expected to include more than 45 countries worldwide, including a number of South African sites. 

Farmovs

FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.   

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients. 

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.  FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.


News Archive

UFS professor receives international recognition for exceptional ethical values
2015-10-02

“You grow so fond of them,” Prof André Venter,
Head: Department of Paediatrics and Child Health,
says while doing his rounds with patients.
Prof Venter recently received the award for health professions
from the international organisation, Unashamedly Ethical.

“You are such a pretty baby,” Prof André Venter, Head: Department of Paediatrics and Child Health at the University of the Free State, whispers to a baby lying stretched out in her neonatal cradle.

He uses his fingertips to free her legs and arms carefully from the monitors and wires attached to her.

“See how much you have grown,” he says, tapping with his finger on her file. 1.2 kg - her weight indicates. 

In one of the other children’s wards, he joins a mother sitting with her sick baby. Speaking about the baby’s operation coming up within the next few months, he gives her an encouraging pat on the shoulder.

He visits yet another mother who is practising kangaroo care on her baby, and asks to hold the baby for a while.

“Gosh, you’re so nice and warm, let doctor hold you for a while,” he says, hugging the premature baby to his chest.

Prof Venter greets and thanks the nursing staff at the end of his ward rounds.

“Everything is not always good, but one can try to plan for the future from the challenges,” he says. “One should never concentrate on the immediate problem too much, but lift the morale of those using our services, those providing the services, and those who come here for training.”

It is this kind of passion and outlook that earned Prof Venter an ethical award from the international organisation, Unashamedly Ethical. The award, which was made in the health professions category, recognises doctors for exceptional ethical values and for going the extra mile in alleviating the suffering of humanity.

“I am humbled at being honoured for something I see as my passion and actually take for granted. I am also touched that people from outside noticed and nominated me for this,” he says.

He talks about his young patients again: “I learn so much from them each day. Children are so resistant to negative things. I grow so fond of them that I forget they have to go home some time.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept